Journal
CELL METABOLISM
Volume 22, Issue 6, Pages 1068-1077Publisher
CELL PRESS
DOI: 10.1016/j.cmet.2015.09.025
Keywords
-
Categories
Funding
- NIH [R01CA129536, R01GM97355, R37DK060596, R01DK053307]
- Carol Baldwin Breast Cancer Research Foundation
- Cancer Research UK [22311] Funding Source: researchfish
Ask authors/readers for more resources
c-Myc is known to promote glutamine usage by upregulating glutaminase (GLS), which converts glutamine to glutamate that is catabolized in the TCA cycle. Here we report that in a number of human and murine cells and cancers, Myc induces elevated expression of glutamate-ammonia ligase (GLUL), also termed glutamine synthetase (GS), which catalyzes the de novo synthesis of glutamine from glutamate and ammonia. This is through upregulation of a Myc transcriptional target thymine DNA glycosylase (TDG), which promotes active demethylation of the GS promoter and its increased expression. Elevated expression of GS promotes cell survival under glutamine limitation, while silencing of GS decreases cell proliferation and xenograft tumor growth. Upon GS overexpression, increased glutamine enhances nucleotide synthesis and amino acid transport. These results demonstrate an unexpected role of Myc in inducing glutamine synthesis and suggest a molecular connection between DNA demethylation and glutamine metabolism in Myc-driven cancers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available